ALK and cancer: Among the 40 cfRNA samples from positive cancer patients, we could identify altered transcripts in 28; including 10 ALK, 6 ROS1, and 7 RET fusion transcripts and 5 MET∆ex14 splicing variants (Fig. 2A).